nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—Nelarabine—Abacavir—acquired immunodeficiency syndrome	0.33	0.417	CrCrCtD
Regadenoson—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.296	0.375	CrCrCtD
Regadenoson—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.164	0.208	CrCrCtD
Regadenoson—Cladribine—POLE3—acquired immunodeficiency syndrome	0.00477	1	CrCbGaD
Regadenoson—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000263	0.00128	CcSEcCtD
Regadenoson—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.00128	CcSEcCtD
Regadenoson—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.00128	CcSEcCtD
Regadenoson—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.00128	CcSEcCtD
Regadenoson—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00128	CcSEcCtD
Regadenoson—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00128	CcSEcCtD
Regadenoson—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.00127	CcSEcCtD
Regadenoson—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.00126	CcSEcCtD
Regadenoson—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000259	0.00126	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000259	0.00126	CcSEcCtD
Regadenoson—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.00126	CcSEcCtD
Regadenoson—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.00126	CcSEcCtD
Regadenoson—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.00126	CcSEcCtD
Regadenoson—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000257	0.00125	CcSEcCtD
Regadenoson—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.00125	CcSEcCtD
Regadenoson—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000256	0.00125	CcSEcCtD
Regadenoson—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000256	0.00125	CcSEcCtD
Regadenoson—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000256	0.00125	CcSEcCtD
Regadenoson—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.00125	CcSEcCtD
Regadenoson—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.00124	CcSEcCtD
Regadenoson—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000255	0.00124	CcSEcCtD
Regadenoson—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000255	0.00124	CcSEcCtD
Regadenoson—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000254	0.00124	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000254	0.00124	CcSEcCtD
Regadenoson—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000253	0.00123	CcSEcCtD
Regadenoson—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00123	CcSEcCtD
Regadenoson—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000252	0.00123	CcSEcCtD
Regadenoson—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000251	0.00122	CcSEcCtD
Regadenoson—Rash—Didanosine—acquired immunodeficiency syndrome	0.00025	0.00122	CcSEcCtD
Regadenoson—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00025	0.00122	CcSEcCtD
Regadenoson—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00025	0.00122	CcSEcCtD
Regadenoson—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00025	0.00122	CcSEcCtD
Regadenoson—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.00122	CcSEcCtD
Regadenoson—Headache—Didanosine—acquired immunodeficiency syndrome	0.000249	0.00121	CcSEcCtD
Regadenoson—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000249	0.00121	CcSEcCtD
Regadenoson—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000248	0.00121	CcSEcCtD
Regadenoson—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.00121	CcSEcCtD
Regadenoson—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.00121	CcSEcCtD
Regadenoson—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000248	0.00121	CcSEcCtD
Regadenoson—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000247	0.00121	CcSEcCtD
Regadenoson—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.00121	CcSEcCtD
Regadenoson—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000247	0.00121	CcSEcCtD
Regadenoson—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.0012	CcSEcCtD
Regadenoson—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000246	0.0012	CcSEcCtD
Regadenoson—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000246	0.0012	CcSEcCtD
Regadenoson—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.0012	CcSEcCtD
Regadenoson—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000245	0.0012	CcSEcCtD
Regadenoson—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000245	0.00119	CcSEcCtD
Regadenoson—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000244	0.00119	CcSEcCtD
Regadenoson—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000244	0.00119	CcSEcCtD
Regadenoson—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000244	0.00119	CcSEcCtD
Regadenoson—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.00119	CcSEcCtD
Regadenoson—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.00119	CcSEcCtD
Regadenoson—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.00119	CcSEcCtD
Regadenoson—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.00119	CcSEcCtD
Regadenoson—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00118	CcSEcCtD
Regadenoson—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.00118	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.00118	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000241	0.00117	CcSEcCtD
Regadenoson—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00117	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00024	0.00117	CcSEcCtD
Regadenoson—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.00117	CcSEcCtD
Regadenoson—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.00117	CcSEcCtD
Regadenoson—Pain—Indinavir—acquired immunodeficiency syndrome	0.000238	0.00116	CcSEcCtD
Regadenoson—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.00116	CcSEcCtD
Regadenoson—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000238	0.00116	CcSEcCtD
Regadenoson—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00116	CcSEcCtD
Regadenoson—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.00116	CcSEcCtD
Regadenoson—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000237	0.00116	CcSEcCtD
Regadenoson—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000237	0.00115	CcSEcCtD
Regadenoson—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000237	0.00115	CcSEcCtD
Regadenoson—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.00115	CcSEcCtD
Regadenoson—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000236	0.00115	CcSEcCtD
Regadenoson—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000236	0.00115	CcSEcCtD
Regadenoson—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.00115	CcSEcCtD
Regadenoson—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000235	0.00115	CcSEcCtD
Regadenoson—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.00115	CcSEcCtD
Regadenoson—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.00114	CcSEcCtD
Regadenoson—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.00114	CcSEcCtD
Regadenoson—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.00114	CcSEcCtD
Regadenoson—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.00114	CcSEcCtD
Regadenoson—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00114	CcSEcCtD
Regadenoson—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000232	0.00113	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.00113	CcSEcCtD
Regadenoson—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00113	CcSEcCtD
Regadenoson—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00112	CcSEcCtD
Regadenoson—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00023	0.00112	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.00112	CcSEcCtD
Regadenoson—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.00112	CcSEcCtD
Regadenoson—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.00112	CcSEcCtD
Regadenoson—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000229	0.00112	CcSEcCtD
Regadenoson—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.00112	CcSEcCtD
Regadenoson—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000228	0.00111	CcSEcCtD
Regadenoson—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000228	0.00111	CcSEcCtD
Regadenoson—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00111	CcSEcCtD
Regadenoson—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.00111	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.00111	CcSEcCtD
Regadenoson—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00111	CcSEcCtD
Regadenoson—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000227	0.00111	CcSEcCtD
Regadenoson—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.0011	CcSEcCtD
Regadenoson—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.0011	CcSEcCtD
Regadenoson—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.0011	CcSEcCtD
Regadenoson—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.0011	CcSEcCtD
Regadenoson—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000225	0.0011	CcSEcCtD
Regadenoson—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000225	0.0011	CcSEcCtD
Regadenoson—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.0011	CcSEcCtD
Regadenoson—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000225	0.0011	CcSEcCtD
Regadenoson—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000224	0.00109	CcSEcCtD
Regadenoson—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000224	0.00109	CcSEcCtD
Regadenoson—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.00109	CcSEcCtD
Regadenoson—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.00109	CcSEcCtD
Regadenoson—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.00109	CcSEcCtD
Regadenoson—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00109	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00108	CcSEcCtD
Regadenoson—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000221	0.00108	CcSEcCtD
Regadenoson—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00108	CcSEcCtD
Regadenoson—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.00108	CcSEcCtD
Regadenoson—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00022	0.00108	CcSEcCtD
Regadenoson—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.00107	CcSEcCtD
Regadenoson—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00022	0.00107	CcSEcCtD
Regadenoson—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000219	0.00107	CcSEcCtD
Regadenoson—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000218	0.00106	CcSEcCtD
Regadenoson—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000218	0.00106	CcSEcCtD
Regadenoson—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.00106	CcSEcCtD
Regadenoson—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.00106	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.00106	CcSEcCtD
Regadenoson—Rash—Stavudine—acquired immunodeficiency syndrome	0.000217	0.00106	CcSEcCtD
Regadenoson—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000217	0.00106	CcSEcCtD
Regadenoson—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.00106	CcSEcCtD
Regadenoson—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.00106	CcSEcCtD
Regadenoson—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000217	0.00106	CcSEcCtD
Regadenoson—Headache—Stavudine—acquired immunodeficiency syndrome	0.000216	0.00105	CcSEcCtD
Regadenoson—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000216	0.00105	CcSEcCtD
Regadenoson—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000216	0.00105	CcSEcCtD
Regadenoson—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000215	0.00105	CcSEcCtD
Regadenoson—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000215	0.00105	CcSEcCtD
Regadenoson—Rash—Abacavir—acquired immunodeficiency syndrome	0.000214	0.00105	CcSEcCtD
Regadenoson—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000214	0.00104	CcSEcCtD
Regadenoson—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.00104	CcSEcCtD
Regadenoson—Headache—Abacavir—acquired immunodeficiency syndrome	0.000213	0.00104	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.00104	CcSEcCtD
Regadenoson—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000212	0.00104	CcSEcCtD
Regadenoson—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00103	CcSEcCtD
Regadenoson—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.00103	CcSEcCtD
Regadenoson—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.00102	CcSEcCtD
Regadenoson—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.00102	CcSEcCtD
Regadenoson—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00102	CcSEcCtD
Regadenoson—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.00102	CcSEcCtD
Regadenoson—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.00102	CcSEcCtD
Regadenoson—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.00101	CcSEcCtD
Regadenoson—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.00101	CcSEcCtD
Regadenoson—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.00101	CcSEcCtD
Regadenoson—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.00101	CcSEcCtD
Regadenoson—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.00101	CcSEcCtD
Regadenoson—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000206	0.00101	CcSEcCtD
Regadenoson—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000205	0.001	CcSEcCtD
Regadenoson—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000205	0.001	CcSEcCtD
Regadenoson—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.001	CcSEcCtD
Regadenoson—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000205	0.001	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.000997	CcSEcCtD
Regadenoson—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.00099	CcSEcCtD
Regadenoson—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000202	0.000985	CcSEcCtD
Regadenoson—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000983	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000982	CcSEcCtD
Regadenoson—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.000977	CcSEcCtD
Regadenoson—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.0002	0.000976	CcSEcCtD
Regadenoson—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000976	CcSEcCtD
Regadenoson—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000976	CcSEcCtD
Regadenoson—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000973	CcSEcCtD
Regadenoson—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000972	CcSEcCtD
Regadenoson—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000972	CcSEcCtD
Regadenoson—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000198	0.000967	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.000951	CcSEcCtD
Regadenoson—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.000947	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000945	CcSEcCtD
Regadenoson—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000944	CcSEcCtD
Regadenoson—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000938	CcSEcCtD
Regadenoson—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000937	CcSEcCtD
Regadenoson—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000936	CcSEcCtD
Regadenoson—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000931	CcSEcCtD
Regadenoson—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000191	0.000931	CcSEcCtD
Regadenoson—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000191	0.00093	CcSEcCtD
Regadenoson—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.00093	CcSEcCtD
Regadenoson—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000928	CcSEcCtD
Regadenoson—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000189	0.000922	CcSEcCtD
Regadenoson—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.000922	CcSEcCtD
Regadenoson—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000189	0.000921	CcSEcCtD
Regadenoson—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000188	0.000916	CcSEcCtD
Regadenoson—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.000906	CcSEcCtD
Regadenoson—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000903	CcSEcCtD
Regadenoson—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000902	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000901	CcSEcCtD
Regadenoson—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000184	0.0009	CcSEcCtD
Regadenoson—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000899	CcSEcCtD
Regadenoson—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000895	CcSEcCtD
Regadenoson—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000893	CcSEcCtD
Regadenoson—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.000882	CcSEcCtD
Regadenoson—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000879	CcSEcCtD
Regadenoson—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.00087	CcSEcCtD
Regadenoson—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000178	0.000869	CcSEcCtD
Regadenoson—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000865	CcSEcCtD
Regadenoson—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000865	CcSEcCtD
Regadenoson—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.00086	CcSEcCtD
Regadenoson—Rash—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000858	CcSEcCtD
Regadenoson—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000857	CcSEcCtD
Regadenoson—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.000854	CcSEcCtD
Regadenoson—Headache—Indinavir—acquired immunodeficiency syndrome	0.000175	0.000852	CcSEcCtD
Regadenoson—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000174	0.00085	CcSEcCtD
Regadenoson—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000841	CcSEcCtD
Regadenoson—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000838	CcSEcCtD
Regadenoson—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.00083	CcSEcCtD
Regadenoson—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000825	CcSEcCtD
Regadenoson—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000817	CcSEcCtD
Regadenoson—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000816	CcSEcCtD
Regadenoson—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.000813	CcSEcCtD
Regadenoson—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.00081	CcSEcCtD
Regadenoson—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.00081	CcSEcCtD
Regadenoson—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000166	0.000808	CcSEcCtD
Regadenoson—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000806	CcSEcCtD
Regadenoson—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000805	CcSEcCtD
Regadenoson—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000785	CcSEcCtD
Regadenoson—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000782	CcSEcCtD
Regadenoson—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000778	CcSEcCtD
Regadenoson—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.000775	CcSEcCtD
Regadenoson—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.000775	CcSEcCtD
Regadenoson—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.00077	CcSEcCtD
Regadenoson—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000769	CcSEcCtD
Regadenoson—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.000763	CcSEcCtD
Regadenoson—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000752	CcSEcCtD
Regadenoson—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000749	CcSEcCtD
Regadenoson—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000749	CcSEcCtD
Regadenoson—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00015	0.00073	CcSEcCtD
Regadenoson—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000724	CcSEcCtD
Regadenoson—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000723	CcSEcCtD
Regadenoson—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000717	CcSEcCtD
Regadenoson—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000716	CcSEcCtD
Regadenoson—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000714	CcSEcCtD
Regadenoson—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000712	CcSEcCtD
Regadenoson—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000696	CcSEcCtD
Regadenoson—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.00069	CcSEcCtD
Regadenoson—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.00069	CcSEcCtD
Regadenoson—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000689	CcSEcCtD
Regadenoson—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000686	CcSEcCtD
Regadenoson—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000675	CcSEcCtD
Regadenoson—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000664	CcSEcCtD
Regadenoson—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000658	CcSEcCtD
Regadenoson—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000658	CcSEcCtD
Regadenoson—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000654	CcSEcCtD
Regadenoson—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.00065	CcSEcCtD
Regadenoson—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.00062	CcSEcCtD
